Provider Assessment Framework: When to Defer or Avoid GLP-1 Therapy Qualified healthcare providers use structured clinical assessment to determine GLP-1 eligibility
(PubMed) Maalouf J, Barron J, Gunn JP, Yuan K, Perrine CG, Cogswell ME
131 TamaiI.NakanishiT.KobayashiD.ChinaK.KosugiY.NezuJ.et al (2004)
Management strategies include eating smaller meals, avoiding high-fat foods (especially on injection day), staying hydrated, and timing your injection when you can rest afterward
Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-B (nuclear factor B) signals
The injectable route of administration used in compounded tirzepatide levocarnitine may partially mitigate this concern